Enlivex Launches 1-for-15 Reverse Stock Split
(RTTNews) - Enlivex Ltd. (ENLV), a clinical-stage immunotherapy company, Tuesday announced a 1-for-15 reverse split of its ordinary shares where every 15 shares will automatically be combined into one ordinary share.
Beginning on July 9, the common shares will trade on a split adjusted basis under the symbol "ENLV" on Nasdaq.
Due to the reverse split, the number of ordinary shares will ratably be reduced from 2,375,000,000 to 158,333,334, and the par value of each ordinary share will ratably increase from NIS 0.40 to NIS 6.00 and the number of Enlivex's issued and outstanding ordinary shares will decrease from 252,480,222 to approximately 16,832,015.
In pre-market activity, ENLV shares were trading at $0.43, down 16.03% on the Nasdaq.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.